chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nausea; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 33-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the left arm on 14Jan2021 (at the age of 33-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9265) via an unspecified route of administration in the left arm on 04Feb2021 (at the age of 33-year-old), both as a single dose for COVID-19 immunisation. Medical history included history of idiopathic pancreatitis, intestines previously severed and repaired following car accident in 1990, anxiety and depression. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included bupropion hydrochloride (WELLBUTRIN SR), lorazepam (ATIVAN) and melatonin (MANUFACTURER UNKNOWN); all for unspecified indication from unknown date and unknown if ongoing. The patient previously received prochlorperazine edisylate (COMPAZINE) for unspecified indication from unknown date and experienced adverse reaction. On an unknown date of 2021, after first dose, the patient experienced two weeks of nausea. On 06Feb2021, after second dose, patient experienced nausea which persisted till the time of reporting. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the event. The clinical outcome of the event nausea was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
developed herpes voster-pain behind the right ear and neck with rash and up into the head started on 1/26/21 and still present on 2/1-rash appears to be crusted over on 2/1/21
This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 54-year-old female patient who received SHINGRIX for prophylaxis. On 11th March 2019, the patient received the 2nd dose of SHINGRIX. In March 2019, less than a week after receiving SHINGRIX, the patient experienced rash. The patient was treated with VALTREX. On an unknown date, the outcome of the rash was unknown. It was unknown if the reporter considered the rash to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on the left arm. The pharmacist reporting that his sister developed a rash after receiving SHINGRIX vaccinated from the reporter. The patient sought medical treatment at a walk-in clinic and was given a prescription for VALTREX. The pharmacist said he was off work on the reporting day, and did not have information related to product lot number, expiration date, or other details that would be at his pharmacy.
3AM on 25MAY95 pt devel inc temp of 104R & had 2 episodes of projectile vomiting;by 6AM elevated temp was reduced to 101R;then by that afternoon pt had improved episode lasting about 24hrs;
Recd SPV on 7/17/2003. On 7/31/2003 developed rash on hands in a glove like distribution. Rash was very pruritic. Reported to emergency room where cultures were done.
Extremely heavy and painful menstrual period began approximately 10 days before it was supposed to start and two days after my first Pfizer vaccine. My menstrual periods have continued to be so heavy and painful ever since my first vaccine date. Huge clots, heavy flow, and abdominal cramps so painful I am unable physically to do my normal everyday activities.
No adverse reaction. Patient was notified. Patient was given Moderna Bivalent Booster 0.25mL dose.
About an hour after vaccine became dizzy the another hour after blood pressure went up with constant irregular heartbeat.  It lasted through the night. I had to take extra blood pressure medication.  I still had the irregular heartbeat for a couple days but blood pressure got under control.
developed shingles; This case was reported by a consumer via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The case was reported by husband of patient.  The age at vaccination was not reported.  The patient developed shingles some time after receiving the first dose of Shingrix.   The patient was currently under the care of her physician. There was consent to follow up.
MMR injection given with well child visit, SQ left upper thigh.  Child unable to settle after injection.  Approximately 10 minutes later reddened raised area approx 8 cm x 6 cm.  Benadryl & Tylenol given as per Dr. - cont to assess x30 minutes.  Reaction site reduced greatly in size prior to leaving the office.
3-4 cm warmth, erythematous mass, burning sensation, pruritic at injection site of varicella.
Diagnosed with burnout, which is ongoing Doctor ordered time off from work, immediately, for at least two months as well as psychotherapy, mindfulness meditation, and daily exercise
Bruises at the site with a size of a dime; It is warm to touch; Sore arm; Hardness on the site; Itchy at site; Red at site; Swelling on the site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Bruises at the site with a size of a dime), VACCINATION SITE WARMTH (It is warm to touch), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE INDURATION (Hardness on the site) and VACCINATION SITE PRURITUS (Itchy at site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.).    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE BRUISING (Bruises at the site with a size of a dime), VACCINATION SITE WARMTH (It is warm to touch), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE INDURATION (Hardness on the site), VACCINATION SITE PRURITUS (Itchy at site), VACCINATION SITE ERYTHEMA (Red at site) and VACCINATION SITE SWELLING (Swelling on the site). At the time of the report, VACCINATION SITE BRUISING (Bruises at the site with a size of a dime), VACCINATION SITE WARMTH (It is warm to touch), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE INDURATION (Hardness on the site), VACCINATION SITE PRURITUS (Itchy at site), VACCINATION SITE ERYTHEMA (Red at site) and VACCINATION SITE SWELLING (Swelling on the site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Dizziness; Nausea; Body aches; Fatigue; Light headedness; This is a spontaneous report from a contactable consumer. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 08Apr2021 at 10:30(at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to tree nuts and shellfish. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 17Mar2021(at the age of 21-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 08Apr2021 at 20:00, the patient experienced dizziness, nausea, body aches, fatigue and light headedness. No therapeutic measures were taken as a result of adverse events. The clinical outcome of the event dizziness, nausea, body aches, fatigue and light headedness were recovering.   No follow-up attempts are needed. No further information is expected.
Localized redness & blisters soon after Td 9-27-10. Saw PMD & was given KEFLEX Rx which pt. filled but didn't take. PC 10/5/10 to me to report area is hard I/CO go ahead & take Rx
Within approximately 2 minutes after receiving the vaccine, patient felt nauseous. His father took him to the bathroom. He did not actually vomit and the feeling passed after using the bathroom. Nurse manager took his vital signs in recovery room: HR 89, BP 100/80, pulse ox 98%. Patient states he feels better. Nurse asked family to stay an additional 5 minutes (total of 20 minutes in the recovery area).
Fever 103, headache, nausea, difficulty breathing, heart burn, muscle pain, joint pain, fatigue, still have headaches and fatigue with heart pain after 2 weeks
patient  received moderna as 1st dose and inadvertently given pfizer as 2nd dose. correct dosage given during both administrations
Pt. had FLUMIST nasal spray at 9 am. Pt. came back to clinic at 2:30 pm with c/o red splotches on chest, back and bilateral arms. Also c/o headache and itching on those areas. Pt stated itching started 30 mins prior to coming back to clinic. Pt stated she felt fine other than redness, headache and itching. Referred to Primary Care Physician for evaluation.
Reddened area to (L) deltoid; warm to touch; painful. Measured 94x66 cm redness. Shot given 1/2/19, symptoms 1/3/19. Prescribed BACTRIM and prednisone.
a 10-month-old patient, was given the 5-11 dilution of the COVID 19 vaccine. No side effects were observed from him other than restlessness during overnight sleeping. The nurse called his mother and informed her of the mix-up shortly after the injection.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), in Jan2021 as dose 2, single (Batch/Lot number: unknown) at the age of 27 years for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "SLE" (unspecified if ongoing); "Lupus nephritis" (unspecified if ongoing); "Rheumatoid Arthritis" (unspecified if ongoing). Concomitant medication(s) included: PLAQUENIL SULFATE, start date: Mar2008; IMURAN [AZATHIOPRINE], start date: Feb2016; METOPROLOL, start date: May2017; BENLYSTA, start date: May2021. Past drug history included: Morphine, reaction(s): "Known allergies: Morphine"; Dilaudid, reaction(s): "Known allergies: Dilaudid". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2023, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 31Oct2023 to 04Nov2023.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300370240 same patient, different drug;
Extreme itchiness at injection site. At this time, there is no raised, red, or hot area. Just pain and a lot of itchiness.
Patient had a history of esophageal atresia with fistula to trachea s/p repair at birth. 2 mo vaccines given 4/22/14. He was admitted 4/24/14 for small bowel obstruction, volvulus, ruptured Meckel's diverticulum.
Patient complained of shock approximately 25 mins after receiving vaccine with muscle spasm and pain that started in the upper part of her body and radiated throughout her entire body. She does not believe it was the vaccines she received since she's had vaccines in the past without issues.
Developed a large local reaction at site of DTaP 3 days after the injection. Resolved with ATARAX.
Patient said arm was swollen and started going down the arm towards wrist.  Was painful and throbbing.  Had been going on for a week before she called.   Patient has tried ice.  I recommended benadryl and nsaids. Then said go to a doctor if no relief today.
We all went for testing and also tested positive; We all went for testing and also tested positive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (003110). The reporter is the patient.  A female patient in her 70's received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "We all went for testing and also tested positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: We all went for testing and also tested positive.  Clinical course: Patient and her husband are in 70's and her son and daughter in-law and 18 month granddaughter live with her. She is a teacher and tested positive for Corvid. They all went for testing and also tested positive. They all had received Pfizer inoculations and boosters and although their tests are positive, They are all functioning very well. We are so very thankful to Pfizer. Without Pfizer where would be, Hospitalized. Thank you Pfizer.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Within 3 or 4 minutes of having received the injection, I had a very odd feeling in the oropharynx and began to cough.  That lasted for 2-3 minutes.  My husband inquired about my welfare.  Then I began another round of coughing which lasted for roughly the same time period.  And then it was gone.   I had no other symptioms
I had vaccination in 10/2022. Within 8 hours I was not feeling well. Shortly thereafter I started to experience flu-like symptoms. These symptoms included fever aches and pains headache lack of energy really hard chills tinnitus and ongoing cough. I did not see a doctor during this time. I am still having the tinnitus on 05/01/2023 and lack of energy.
After receiving first dose of Pfizer, patient became pale, c/o feeling dizzy.  Patient helped into wheelchair to stretcher.  Patient fainted, then woke up and still c/o feeling dizzy. At that time two doctors were available and assessed the patient. Vital Signs: BP 90/63; Temp 97.9; Pulse 59; Resp Rate 18; Doctors thought patient had a vagal response and was okay. Patient was watched for one hour. During that time patient felt better and denied dizziness. Vital signs at discharged: BP 96/72; Pulse 79; Resp Rate 18.
This nurse was told by the pt's caregiver that they were advised by the health department that they were eligible to receive the vaccine at the time of a visit to Schools in order to vaccinate school teachers as well as the general public who were elderly or those caring for someone with special needs.  Due to the fact that they were told by the health department they were good to get the vaccine I went ahead and vaccinated the pt as well as her mother and caregiver.  However, Moderna vaccine has not been approved for patients under 18 years of age at this time.  I notified the health department and the told me to fill out this VAERS form so as to make sure it is documented that the patient received the moderna vaccine at this time.  There has been no adverse effect of the vaccine as of this time.
pt had fever of 102-103 x 2 days following DTp inject; grandma describes episode of shaking episode occurred approx 4-5 hrs following inject; mom gave APPA & cool baths; no tx from MD; pt to recvd ped DT;
Information has been received from a pharmacist concerning a 73 year old female with Parkinson's disease and drug reactions/allergies to AVELOX who on 31-AUG-2010 was vaccinated subcutaneously into right arm with a 0.65 ml dose of ZOSTAVAX (Merck). The lot # was 664630/0837Y, and the expiry date would be 17-DEC-2010. Concomitant therapy included XANAX, REQUIP, carbidopa/levodopa (manufacturer unknown), amantadine hydrochloride (manufacturer unknown) and EXELON. On 31-AUG-2010 the patient within 30 minutes of receiving ZOSTAVAX (Merck) experienced redness of her lower right arm. The patient was recovering from redness of her lower right arm. The patient sought unspecified medical attention. No diagnostic laboratory tests were performed. Follow-up information was received from a physician who stated that she did not examine the patient for the problem relayed to her. The patient had a mild erythema down her arm. The patient's erythema was resolved without problem. Lab diagnostics studies were not performed. Additional information is not expected.
Experiencng redness around the injection site; Experienced some pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Experienced some pain at the injection site) and VACCINATION SITE ERYTHEMA (Experiencng redness around the injection site) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 12-Mar-2021, the patient experienced VACCINATION SITE PAIN (Experienced some pain at the injection site). On 16-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Experiencng redness around the injection site). On 16-Mar-2021, VACCINATION SITE PAIN (Experienced some pain at the injection site) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Experiencng redness around the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant product use was reported.  Treatment for the events included application of ice onto the injection site.   Reporter did not allow further contact
Information has been received from a registered nurse concerning another nurse who splashed measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) in her eye while drawing it from the vile. On 03-OCT-2007 the right side of her face that was splashed was itching slightly. The patient flushed her eye with H2O. The patient did not seek medical attention. At the time of the report the patient reported "I have no further complaints to report". A product quality complaint was not involved. Additional information is not expected.
Patient tolerated vaccine fine with no immediate reaction or issues, waited normal 15 minutes and then left.  Approximately 2 hours post vaccination the patient started experiencing leg numbness in her left leg.  She stated it felt like "jello" and was weak.  She declined the option to immediately return to the clinic for a provider evaluation.  She stated no trouble breathing of any kind.  She said she had consulted her oncologist and "healthcare team".   She did mention her specialist was pausing some of her medications in order to receive the covid vaccine and that she had okayed her to receive it.
day after vaccine:sharp little head pains, very sore neck on left side and upper shoulders & back. later same day chills in upper torso only, lethargic. day 2, fine.  day 3 &4  re and swelling from above elbow to shoulder-left arm, then continued on left clavicle to chin line on left.  I have a 3" area in the middle of that from shoulder to clavicle that is unaffected.  Looks like sunburn lines
The day after the vaccine the patient reported she had flu like symptoms (achy and tired).  The reaction site was red and swollen.  She also stated she had a cough afterwards too.
Shortness of breath on day of shot. Next 2 days I had chest pains by my heart/left breast. Shortness of breath persisted until day of this report 12/9/21
The patient stated that he had arrived at the hospital to receive his second dose of the COVID-19 vaccine. The patient had no vaccination record card on hand. I administered a dose of the Pfizer-BioNTech vaccine, and while drawing up a vaccine record, I then saw in the patient's record that his first vaccine had been a Moderna vaccine administered on 1/22/21. I informed the patient of my mistake and asked him to wait for a period of at least 30 minutes in the vaccine administration instead of the usual 15 minutes. The patient reported no feelings of illness or discomfort. After 35 minutes in the observation area, the patient said he was tired of waiting and that he did not feel unwell or unusual. The patient said he would return to the hospital if he ever felt ill.
Blue lips, Loss of Consciousness on 05/16/2013; taken to doctor's office, diagnosed with Severe Anemia and sent to another Hospital for further tests.
Patient is a 61 y.o. female patient with history of  of COPD. ILD, RA, Anxiety, DDD of L spine, T2DM, HTN, HLD , Chronic pain syndrome presented to Hospital.   Acute delirium from combination of COVID-19 infection and behavioral health issues Suicidal Ideation Extensive psych history, was recently discharged from BH on 2/9 Currently alert and oriented, denies SI/HI CTH No acute findings.  No hemorrhage or mass. Brain atrophy stable.  No hydrocephalus Blood work non revaling, other than positive for COVID19 UA WNL, UDS benzos and opiates positive, TSH 0.28, B-12 742 Consult BH, appreciate assistance Had an episode of attempting to hang herself in her room 2/15 Per BH, palliative care consult recommended and placed. Appreciate assistance BHU OK with discharge once medically cleared and safe discharge plan arranged Palliative and CM helped determine to discharge with return to hospice at home Sister with some concerns prior to discharge, Psych agreed to call her the morning after discharge to discuss her behavioral issues   Nausea/Vomiting Nausea and vomiting still intermittently present, but improved May be secondary to COVID Tolerating PO and ok with discharge Hospice to help manage potential anti-emetics   Chronic hypoxic respiratory failure COVDI19 pneumonia ILD COPD/Asthma CXR Worsening of the mixed interstitial and alveolar opacities in the perihilar regions and lower lungs from the prior study suggesting superimposed edema or pneumonitis on chronic interstitial changes. On chronic 4 L O2 therapy. IV lasix 40 mg one dose, cont po lasix 40mg qd Mucinex, IS/PEP, Check CRP Monitor on continuous pulse ox .  Hold home p.o. prednisone and switch to IV Decadron given elevated CRP Continue breathing treatments and bronchodilator therapy   HTN HLD Resume coreg and lisinopril Resume statin Monitor and adjust BP medication as able   T2DM with hyperglycemia Poorly controled.  A1c 8.8 Lantus and SSI adjusted  Adjust insulin as able.    Chronic leukocytosis Normocytic anemia Likely from steroid, WBC 14, Hg stable at 10.9 monitor